ReviewCancers2021

NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images.

Virginia Liberini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.